WebHRMY - key executives, insider trading, ownership, revenue and average growth rates. Detailed company description & address for Harmony Biosciences Holdings Inc.. WebHRMY: Lowering target price to $32.00 HARMONY BIOSCIENCES HOLDINGS has an Investment Rating of HOLD; a target price of $32.000000; an Industry Subrating of Medium; a Management Subrating of...
Enhabit Home Health & Hospice - Investor Relations
WebHRMY Harmony Biosciences Holdings, Inc. Common Stock (HRMY) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Charts Key Data Bid Price and Ask … WebInvestor Relations Providing a better way to care by expanding what's possible for patient care in the home. Corporate Overview Enhabit is a leading provider of home health and … mayslake photography club
Harmony Biosciences Holdings, Inc. (HRMY) Earnings Transcripts
Web4 mei 2024 · HRMY earnings call for the period ending March 31, 2024. ... [Operator instruction] I will now turn the call over to Luis Sanay, head of investor relations. Please go ahead. Web1 dag geleden · In 2024, HRMY's revenue was $437.86 million, an increase of 43.35% compared to the previous year's $305.44 million. Earnings were $181.47 million, an increase of 424.52%. Financial Statements Analyst Forecast According to 14 analysts, the average rating for HRMY stock is "Buy." Web24 mrt. 2024 · HRMY -0.26% DJIA 0.41% S&P Mid Cap 400 0.74% Health Care/Life Sciences 1.19% Overview Luis Sanay Head-Investor Relations, Harmony Biosciences Holdings, Inc. Presently, Luis Sanay occupies the... mayslack\\u0027s northeast minneapolis